Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process

Neoadjuvant chemotherapy (NC) improves overall survival in patients with resectable muscle-invasive urothelial cancer of the bladder (MIBC). However uptake of NC in Canada is dis-appointingly low. Following a detailed literature review and in consultation with urologic oncology, the Canadian Associa...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Seah, Jo-An, Blais, Normand, North, Scott, Rahim, Yasmin, Ruether, Dean, Black, Peter C., Zlotta, Alexandre R., Wood, Lori, Sridhar, Srikala S.
פורמט: Artigo
שפה:Inglês
יצא לאור: Canadian Medical Association 2013
נושאים:
Consensus Statement
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854467/
https://ncbi.nlm.nih.gov/pubmed/24319508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.1506
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים